Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Institutional Ownership: 0.44% (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
82 GF Score
Price ¥7.72
GF Value ¥9.44
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co Institutional Ownership?

Zhejiang Ausun Pharmaceutical Co SHSE:603229 -2.15% 82 Institutional Ownership is 0.44% as of Sep. 10, 2026. GuruFocus rates SHSE:603229 with a GF Score™ of 82/100 and a GF Value™ of ¥9.44 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Zhejiang Ausun Pharmaceutical Co's institutional ownership is 0.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Zhejiang Ausun Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Zhejiang Ausun Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Zhejiang Ausun Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co Institutional Ownership Chart

Zhejiang Ausun Pharmaceutical Co Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 1.66 1.52 1.51 1.51 1.51 1.51 1.51 0.44 0.44 0.44
SHSE:603229
82GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Ausun Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.44% mean?
Zhejiang Ausun Pharmaceutical Co (SHSE:603229) has a Institutional Ownership of 0.44% as of Sep. 10, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors.
Is Zhejiang Ausun Pharmaceutical Co's Institutional Ownership too high?
Zhejiang Ausun Pharmaceutical Co's current Institutional Ownership is 0.44%. Overall, Zhejiang Ausun Pharmaceutical Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Ausun Pharmaceutical Co's Institutional Ownership compare to VRTX and REGN?
Zhejiang Ausun Pharmaceutical Co's Institutional Ownership of 0.44% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Zhejiang Ausun Pharmaceutical Co and its competitors. Zhejiang Ausun Pharmaceutical Co's current Institutional Ownership is 0.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Ausun Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co (SHSE:603229) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥9.44, compared to a current price of ¥7.72 — trading 18.2% below its estimated fair value. The current Institutional Ownership is 0.44%. Zhejiang Ausun Pharmaceutical Co's overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Zhejiang Ausun Pharmaceutical Co (SHSE:603229), the current Institutional Ownership is 0.44% as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.72 is trading 18.2% below its estimated GF Value™ of ¥9.44. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • Institutional Ownership: 0.44%
  • GF Value™: ¥9.44 vs. price of ¥7.72 (18.2% below fair value)
  • GF Score™: 82/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
82GF Score

Get the complete analysis for SHSE:603229

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.72
Price
¥9.44
GF Value